跳至主要内容
临床试验/ACTRN12613001028796
ACTRN12613001028796已完成3 期

Efficacy of the Apitherapy in the treatment of recalcitrant localized plaque psoriasis and evaluation of Tumor Necrosis Factor-Alpha (TNF-a) serum level: Double blind randomized clinical trial.

Faculty of Medicine, Suez Canal University, prof. Atef Elakhras0 个研究点目标入组 50 人开始时间: 2013年9月16日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 60 Years(—)
性别
All

入选标准

  • *Patients diagnosed as recalcitrant localized psoriasis.
  • *Patients aged 18 -60 years.
  • *Both genders.
  • *Stopping any topical or systemic treatment for psoriasis during the last 2 months.

排除标准

  • *Patient who had any allergic disorder.
  • *Patient who had reactions to bee stings.
  • *Patient who are responding well to conventional treatment.
  • *Pregnancy and lactation.
  • *Systemic diseases such as diabetes and cardiac diseases

研究者

发起方
Faculty of Medicine, Suez Canal University, prof. Atef Elakhras

相似试验

Efficacy of the Apitherapy in the treatment of... | 临床试验